_id

690db5aeccc777a4e85d0dd5

Ticker

BCDA

Name

Biocardia Inc

Exchange

NASDAQ

Address

320 Soquel Way, Sunnyvale, CA, United States, 94085

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.biocardia.com

Description

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. It is also developing an allogeneic cells therapy platform, which is an investigational culture expanded bone marrow derived mesenchymal cell therapy in Phase I/II trial to treat ischemic heart failure and acute respiratory distress syndrome. In addition, the company offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; and Morph deflectable guides and sheaths products. It has collaboration agreements with CellProthera in the development of ProtheraCytes, which is currently under Phase II trial for the treatment of acute myocardial infarction. It also has a development and commercialization agreement with CART-Tech, B.V. for the development of Heart3D Fusion Imaging system. BioCardia, Inc. is based in Sunnyvale, California.

Last Close

1.47

Volume

94652

Current Price

1.45

Change

-1.360544217687076

Last Updated

2025-11-28T12:45:10.520Z

Image

-

Ipo Date

2008-03-14T00:00:00.000Z

Market Cap

15176209

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.8959999999999999

Sentiment Sources

5

Rating

5

Target Price

15.5

Strong Buy

1

Buy

0

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

107000

Gross Profit

-107000

Operating Expenses

1381000

Operating Income

-1488000

Interest Expense

-

Pretax Income

-1483000

Net Income

-1483000

Eps

-236.22737083555674

Dividends Per Share

-

Shares Outstanding

10612734

Income Tax Expense

-

EBITDA

-1376000

Operating Margin

-

Total Other Income Expense Net

5000

Cash

5287000

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

5365000

Property Plant Equipment

612000

Total Assets

6148000

Payables

1080000

Short Term Debt

427000

Long Term Debt

-

Total Liabilities

3521000

Equity

2627000

Depreciation

107000

Change In Working Capital

-309000

Cash From Operations

-1672000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

5979000

Net Change In Cash

4307000

PE

-

PB

0.0034651246669204416

ROE

-56.45222687476209

ROA

-24.121665582303187

FCF

-1672000

Fcf Percent

-

Piotroski FScore

0

Health Score

31

Deep Value Investing Score

5

Defensive Investing Score

6

Dividend Investing Score

1.5

Economic Moat Investing Score

3.3

Garp Investing Score

1

Growth Investing Score

0.5

Momentum Investing Score

2.5

Net Net Investing Score

3

Quality Investing Score

2

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

107000

Quarters > 0 > income Statement > gross Profit

-107000

Quarters > 0 > income Statement > operating Expenses

1381000

Quarters > 0 > income Statement > operating Income

-1488000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-1483000

Quarters > 0 > income Statement > net Income

-1483000

Quarters > 0 > income Statement > eps

-236.22737083555674

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

6277.85

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-1376000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

5000

Quarters > 0 > balance Sheet > cash

5287000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

5365000

Quarters > 0 > balance Sheet > property Plant Equipment

612000

Quarters > 0 > balance Sheet > total Assets

6148000

Quarters > 0 > balance Sheet > payables

1080000

Quarters > 0 > balance Sheet > short Term Debt

427000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

3521000

Quarters > 0 > balance Sheet > equity

2627000

Quarters > 0 > cash Flow > net Income

-1483000

Quarters > 0 > cash Flow > depreciation

107000

Quarters > 0 > cash Flow > change In Working Capital

-309000

Quarters > 0 > cash Flow > cash From Operations

-1672000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

5979000

Quarters > 0 > cash Flow > net Change In Cash

4307000

Quarters > 0 > ratios > PE

-236.22737083555674

Quarters > 0 > ratios > PB

0.0034651246669204416

Quarters > 0 > ratios > ROE

-56.45222687476209

Quarters > 0 > ratios > ROA

-24.121665582303187

Quarters > 0 > ratios > FCF

-1672000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

31

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

1368000

Quarters > 1 > income Statement > gross Profit

-1368000

Quarters > 1 > income Statement > operating Expenses

683000

Quarters > 1 > income Statement > operating Income

-2051000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-2049000

Quarters > 1 > income Statement > net Income

-2049000

Quarters > 1 > income Statement > eps

-0.40496183990627177

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

5059736

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-2045999

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

2000

Quarters > 1 > balance Sheet > cash

980000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

10000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

1199000

Quarters > 1 > balance Sheet > property Plant Equipment

719000

Quarters > 1 > balance Sheet > total Assets

2089000

Quarters > 1 > balance Sheet > payables

1233000

Quarters > 1 > balance Sheet > short Term Debt

412000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

3975000

Quarters > 1 > balance Sheet > equity

-1886000

Quarters > 1 > cash Flow > net Income

-2049000

Quarters > 1 > cash Flow > depreciation

104000

Quarters > 1 > cash Flow > change In Working Capital

134000

Quarters > 1 > cash Flow > cash From Operations

-1649000

Quarters > 1 > cash Flow > capital Expenditures

1000

Quarters > 1 > cash Flow > cash From Investing

-1000

Quarters > 1 > cash Flow > cash From Financing

1681000

Quarters > 1 > cash Flow > net Change In Cash

31000

Quarters > 1 > ratios > PE

-0.40496183990627177

Quarters > 1 > ratios > PB

-3.8900409331919406

Quarters > 1 > ratios > ROE

108.64262990455991

Quarters > 1 > ratios > ROA

-98.08520823360459

Quarters > 1 > ratios > FCF

-1650000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

39

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

1530000

Quarters > 2 > income Statement > gross Profit

-1530000

Quarters > 2 > income Statement > operating Expenses

1196000

Quarters > 2 > income Statement > operating Income

-2726000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-2712000

Quarters > 2 > income Statement > net Income

-2712000

Quarters > 2 > income Statement > eps

-0.9883381924198251

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

2744000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-2714000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

14000

Quarters > 2 > balance Sheet > cash

949000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

1173000

Quarters > 2 > balance Sheet > property Plant Equipment

822000

Quarters > 2 > balance Sheet > total Assets

2166000

Quarters > 2 > balance Sheet > payables

818000

Quarters > 2 > balance Sheet > short Term Debt

398000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

3686000

Quarters > 2 > balance Sheet > equity

-1520000

Quarters > 2 > cash Flow > net Income

-2712000

Quarters > 2 > cash Flow > depreciation

12000

Quarters > 2 > cash Flow > change In Working Capital

815000

Quarters > 2 > cash Flow > cash From Operations

-1618000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

196000

Quarters > 2 > cash Flow > net Change In Cash

-1422000

Quarters > 2 > ratios > PE

-0.9883381924198251

Quarters > 2 > ratios > PB

-2.617631578947368

Quarters > 2 > ratios > ROE

178.42105263157896

Quarters > 2 > ratios > ROA

-125.20775623268699

Quarters > 2 > ratios > FCF

-1618000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

39

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

-58000

Quarters > 3 > income Statement > cost Of Revenue

1415000

Quarters > 3 > income Statement > gross Profit

-1415000

Quarters > 3 > income Statement > operating Expenses

906000

Quarters > 3 > income Statement > operating Income

-2321000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-2296000

Quarters > 3 > income Statement > net Income

-2296000

Quarters > 3 > income Statement > eps

-0.8367346938775511

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

2744000

Quarters > 3 > income Statement > income Tax Expense

-62724

Quarters > 3 > income Statement > EBITDA

-2306000

Quarters > 3 > income Statement > operating Margin

4001.724137931034

Quarters > 3 > income Statement > total Other Income Expense Net

25000

Quarters > 3 > balance Sheet > cash

2371000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

0

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

2622000

Quarters > 3 > balance Sheet > property Plant Equipment

931000

Quarters > 3 > balance Sheet > total Assets

3724000

Quarters > 3 > balance Sheet > payables

385000

Quarters > 3 > balance Sheet > short Term Debt

385000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

2887000

Quarters > 3 > balance Sheet > equity

837000

Quarters > 3 > cash Flow > net Income

-2296000

Quarters > 3 > cash Flow > depreciation

15000

Quarters > 3 > cash Flow > change In Working Capital

-563000

Quarters > 3 > cash Flow > cash From Operations

-2573000

Quarters > 3 > cash Flow > capital Expenditures

1000

Quarters > 3 > cash Flow > cash From Investing

-1000

Quarters > 3 > cash Flow > cash From Financing

15000

Quarters > 3 > cash Flow > net Change In Cash

-2559000

Quarters > 3 > ratios > PE

-0.8367346938775511

Quarters > 3 > ratios > PB

4.753643966547192

Quarters > 3 > ratios > ROE

-274.31302270011946

Quarters > 3 > ratios > ROA

-61.65413533834586

Quarters > 3 > ratios > FCF

-2574000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

44.37931034482759

Quarters > 3 > health Score

29

Valuation > metrics > PE

-236.22737083555674

Valuation > metrics > PB

0.0034651246669204416

Valuation > final Score

70

Valuation > verdict

99.7% Undervalued

Profitability > metrics > ROE

-56.45222687476209

Profitability > metrics > ROA

-27.642124883504195

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

1.3403121431290446

Risk > metrics > Interest Coverage

-13.906542056074766

Risk > final Score

-26

Risk > verdict

High

Liquidity > metrics > Current Ratio

3.560053085600531

Liquidity > metrics > Quick Ratio

3.560053085600531

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

32.46356033452808

Prev Profitabilities > 0

55

Prev Profitabilities > 1

55

Prev Profitabilities > 2

30

Prev Risks > 0

-2704

Prev Risks > 1

-5422

Prev Risks > 2

-922

Prev Liquidities > 0

46

Prev Liquidities > 1

58

Prev Liquidities > 2

100

Updated At

2025-12-14T00:16:01.704Z